Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2017
Pharma News, 2017
Takeda gains exclusive global rights to gastroenterology candidate
Japanese drugmaker Takeda Pharmaceutical (TYO.
FDA approves drugs more quickly than peer agency in Europe: study
The U.
Combination of Optune™ with Standard of Care Chemotherapy, Temozolomide, Provides Landmark Five-Year Survival Rates for Newly Diagnosed Glioblastoma Patients
ST.
Canadian biopharma company Zymeworks files for U.S. IPO
Canadian biopharmaceutical company Zymeworks said it has filed with the U.
Scientists find common antibiotic could prevent or treat PTSD
LONDON - A common antibiotic called doxycycline can disrupt the formation of negative thoughts and fears in the brain and may prove useful in treating or preventing post-traumatic stress disorder (...
Maple syrup extract may dramatically increase the potency of antibiotics
Toronto.
Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
JERUSALEM--(BUSINESS WIRE)--Apr.
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia
BOSTON, April 03, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc.
Low-dose aspirin can reduce risk of death from cancer, research says
An aspirin a day may keep the doctor away.
Sanofi to pay $19.8 million over claims of drug overcharges: U.S.
Sanofi SA (SASY.
Astellas to buy GPCR specialist Ogeda for €500M upfront
Astellas has struck a deal to buy Ogeda for €500 million ($534 million) upfront.
Hepatitis B, C may raise risk of Parkinson's disease
London.
52
53
54
55
56
57
58
59
60
